South Korea Research Antibodies Market Size & Outlook
The research antibodies market in South Korea is expected to reach a projected revenue of US$ 130.6 million by 2033. A compound annual growth rate of 10.5% is expected of South Korea research antibodies market from 2026 to 2033.
In terms of revenue, South Korea accounted for 3.0% of the global research antibodies market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China research antibodies market is projected to lead the regional market in terms of revenue in 2033.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 219.6 million by 2033.
Increase in the number of public and private sector initiatives being undertaken to expand biotechnology industry is expected to fuel the market growth. In 2018, Korean Biotechnology Industry Organization announced that ABL Bio, a biotech research organization, attracted an investment of USD 58 million from 10 venture capital companies.
Therefore, increase in private and public funds for research is expected to lead to an increase in the usage of antibodies in various therapeutic, diagnostic, and research applications.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Research Antibodies Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 63.9% in 2025.
Horizon Databook has segmented the South Korea research antibodies market based on polyclonal antibodies, monoclonal antibodies covering the revenue growth of each sub-segment from 2021 to 2033.
Increase in the number of public and private sector initiatives being undertaken to expand biotechnology industry is expected to fuel the market growth. In 2018, Korean Biotechnology Industry Organization announced that ABL Bio, a biotech research organization, attracted an investment of USD 58 million from 10 venture capital companies.
Therefore, increase in private and public funds for research is expected to lead to an increase in the usage of antibodies in various therapeutic, diagnostic, and research applications.
South Korea Research Antibodies Market Specificity Outlook (Revenue, USD Million , 2021-2033)
Polyclonal Antibodies
Monoclonal Antibodies
South Korea Research Antibodies Market Product Outlook (Revenue, USD Million , 2021-2033)
Primary
Secondary
South Korea Research Antibodies Market Technology Outlook (Revenue, USD Million , 2021-2033)
Western blotting
Flow cytometry
Immunofluorescence
Immunohistochemistry
Immunoprecipitation
ELISA
Others Technology
South Korea Research Antibodies Market Source Outlook (Revenue, USD Million , 2021-2033)
Rabbit
Goat
Mice
Others Source
South Korea Research Antibodies Market Applications Outlook (Revenue, USD Million , 2021-2033)
Oncology
Stem Cells
Others Applications
Infectious Diseases
Immunology
Neurobiology
South Korea Research Antibodies Market End Use Outlook (Revenue, USD Million , 2021-2033)
Contract Research Organizations
Pharma & Biotech Companies
Academic & Research Institutes
Reasons to subscribe to Research Antibodies Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Research Antibodies Market Outlook databook
Our clientele includes a mix of Research Antibodies Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Research Antibodies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Research Antibodies Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Research Antibodies Market, 2021-2033 (US$M)